A Repeated Dose Study of KHK6640 in Japanese Patients With Alzheimer's Disease

Summary

The purpose of this study is to evaluate the safety, tolerability and pharmacokinetics of KHK6640, given as a repeated dose in Japanese patients with Mild to Moderate Alzheimer's Disease.

Timeline

Start

2017-03-03

Primary completion

2017-12-06

Completion

2017-12-06

Drugs

Indications